Organo Biotech Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 15-12-2024
- Paid Up Capital ₹ 3.00 M
as on 15-12-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.79 M
as on 15-12-2024
- Revenue 38.95%
(FY 2023)
- Profit -91.72%
(FY 2023)
- Ebitda 58.32%
(FY 2023)
- Net Worth 0.26%
(FY 2023)
- Total Assets -21.70%
(FY 2023)
About Organo Biotech Laboratories
The Corporate was formerly known as Organo Mediwares Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹9.79 M.
Rajinder Chopra and Arunima Chopra serve as directors at the Company.
- CIN/LLPIN
U74900DL2008PTC175507
- Company No.
175507
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Organo Biotech Laboratories Private Limited offer?
Organo Biotech Laboratories Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Bio Chemicals, Laboratory Reagents, Scientific Instruments, Laboratory Instruments, Dyes & Color Additives, Basic Dyes, Pathology Lab Equipments, Needle Cutters and Destroyers, Laboratory & Pharmaceutical Ovens.
Who are the key members and board of directors at Organo Biotech Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajinder Chopra  | Director | 18-Mar-2008 | Current |
| Arunima Chopra | Director | 18-Mar-2008 | Current |
Financial Performance of Organo Biotech Laboratories.
Organo Biotech Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.95% increase. The company also saw a substantial fall in profitability, with a 91.72% decrease in profit. The company's net worth moved up by a moderate rise of 0.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Organo Biotech Laboratories?
Unlock access to Organo Biotech Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Organo Diagnostics Private LimitedActive 12 years 8 monthsRajinder Chopra and Arunima Chopra are mutual person
- Radhika Raman FoundationActive 2 months 11 days
Rajinder Chopra and Arunima Chopra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 07 Aug 2020 | ₹1.60 M | Open |
Syndicate Bank Creation Date: 30 Aug 2014 | ₹0.19 M | Open |
Others Creation Date: 23 Apr 2010 | ₹8.00 M | Open |
How Many Employees Work at Organo Biotech Laboratories?
Unlock and access historical data on people associated with Organo Biotech Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Organo Biotech Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Organo Biotech Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
